Antonio Regalado Bio: MIT Technology Review Editor’s Age, Career, Family, Why He’s Famous & Recent 2026 Investigative Works

Antonio Regalado is a world-renowned American investigative journalist and the Senior Editor for Biomedicine at MIT Technology Review, widely recognized for his groundbreaking coverage of genetic engineering and biotechnology. This Antonio Regalado bio explores the life of the man who famously broke the story of the world’s first CRISPR-edited babies, his transition from traditional financial reporting to cutting-edge science journalism, and his continued influence on global bioethics in 2026.

Quick Facts

Early Life & Education

Childhood

Antonio Regalado was raised in an environment that valued intellectual curiosity and global perspectives. While he keeps much of his early family life private, it is known that his Hispanic heritage played a role in his later interest in international reporting. Growing up in the United States, he displayed an early aptitude for writing and critical analysis, often questioning the intersection of technology and human society.

School Years

During his formative years, Regalado was an exceptional student, particularly in the humanities and social sciences. He developed a reputation for being a “tenacious researcher,” a trait that would later define his career as one of the most feared and respected investigative journalists in the science sector.

University & Training

Antonio attended Yale University, where he honed his skills in narrative non-fiction and investigative techniques. He graduated with a Bachelor of Arts, focusing on subjects that allowed him to bridge the gap between complex technical data and public understanding. His time at Yale was instrumental in building the network and the foundational skepticism required for high-stakes journalism.

Career Journey

Career Beginnings at the Wall Street Journal

Antonio Regalado began his professional journey at the Wall Street Journal (WSJ), where he served as a foreign correspondent. Based for several years in Brazil, he covered Latin American politics, business, and economics. This period was crucial in developing his ability to track “follow-the-money” stories, which he would later apply to the secretive world of biotechnology labs.

During his tenure at the WSJ, Regalado shifted his focus toward science and technology. He realized that the most significant shifts in human history were no longer happening on trade floors, but in the microscopic world of DNA and cellular biology.

Transition to MIT Technology Review

In 2011, Regalado joined MIT Technology Review as the Senior Editor for Biomedicine. This move allowed him to specialize in “frontier science.” He became the primary voice covering the burgeoning field of genomics, longevity research, and the ethical quagmires of Silicon Valley’s “immortality” startups.

The CRISPR Scoop: A Career Milestone

In November 2018, Regalado achieved international fame—and sparked a global ethical crisis—when he broke the story of He Jiankui, the Chinese scientist who had used CRISPR technology to create the first gene-edited human infants. Regalado’s investigative work uncovered documents and secret clinical trials that the scientific community had been unaware of, leading to immediate international condemnation and a paradigm shift in how gene editing is regulated globally.

Recent 2026 Investigative Works

As of 2026, Antonio Regalado remains at the forefront of bio-investigative journalism. His recent work has shifted toward:

• AI-Generated Pathogens: Investigating the risks of “black box” AI models that can design novel biological agents.
• The De-Extinction Economy: A deep dive into the 2025–2026 commercialization of mammoth and dodo “revival” projects.
• Bio-Privacy in the Age of Neural Links: An exposé on how private corporations are beginning to “harvest” neural data from early adopters of brain-computer interfaces.

Career Bibliography & Notable Reports

Net Worth & Earnings

As a career journalist and senior editor at a prestigious institution like MIT, Antonio Regalado’s net worth is estimated to be between $1.5 million and $3 million in 2026.

Unlike tech entrepreneurs, his wealth is built on professional stability, speaking engagements, and potentially lucrative book deals related to his investigative scoops. His primary income streams include:

• Salary: High-level editorial position at MIT Technology Review.
• Speaking Fees: Regalado is a frequent keynote speaker at bioethics and technology summits (BioTech Echo 2025, Davos Tech 2026).
• Consulting & Awards: Recognition from various journalism fellowships and prize purses.

Personal Life

Family Background

Antonio is known for maintaining a sharp boundary between his professional work and his private life. He rarely discusses his parents or siblings in the media, focusing the spotlight instead on the scientists and ethics he covers.

Marriage & Spouse

Regalado is married and resides in the greater Boston area, a hub for the biotechnology industry he covers. His family life is kept out of the public eye to ensure the safety and privacy of his relatives, given the often-controversial nature of his reporting.

Hobbies & Interests

When he isn’t in the lab or at his desk, Antonio is an avid reader of classic literature and a follower of international politics. He maintains an interest in Latin American culture, a remnant of his years as a foreign correspondent.

Controversies & Legal Issues

The “He Jiankui” Ethical Fallout (2018–2020)

While not a controversy of his own making, Regalado was at the center of a firestorm regarding journalistic ethics. Some critics questioned the timing of his report, but the consensus remained that his “whistleblowing” through journalism prevented further unregulated human experimentation.

Legal Threats from Bio-Startups

Throughout 2024 and 2025, Regalado faced several legal “cease and desist” orders from secretive Silicon Valley startups. His refusal to back down from reporting on the failures of experimental gene therapies has made him a polarizing figure among tech-optimists but a hero to consumer safety advocates.

Awards & Achievements

• George Polk Award: For Science Reporting (Recognizing his CRISPR coverage).
• Cavli Science Journalism Award: Multiple-time finalist and winner.
• Finalist for the Pulitzer Prize: Specifically cited for his investigative depth in biotechnology.
• Top 10 Most Influential Tech Journalists (2026): Ranked by the Global Media Council.

Physical Statistics

• Height: 5’10” (178 cm)
• Weight: 75 kg (165 lbs)
• Fitness Routine: Enjoys cycling and hiking around the Massachusetts coastline to disconnect from the digital world.

Quotes

“The problem with ‘changing the human race’ is that the human race didn’t get a vote.” — Interview with BBC, 2024

“Journalism isn’t just about what is happening; it’s about what people are trying to hide in the name of progress.” — Keynote Address, 2025

Interesting Facts

• Polyglot: Antonio is fluent in English, Spanish, and Portuguese.
• Traveler: He has reported from over 30 countries across four continents.
• Early Tech Adopter: He was one of the first journalists to deeply investigate the “Bio-Hacking” community in the early 2010s.
• Academic Influence: His articles are frequently used as case studies in university bioethics courses.
• Low Profile: Despite his fame in the science world, he rarely uses social media for personal updates, preferring professional dissemination of facts.
• Data Driven: He is known to learn basic coding and data scraping to uncover hidden clinical trial results.
• Longevity Skeptic: Despite covering “immortality” startups, he is famously skeptical of unproven anti-aging supplements.
• Anonymous Sources: He maintains one of the most robust networks of “whistleblower” sources in the global biotech industry.

Did You Know?

• Did you know Antonio Regalado was the first to reveal that Jeff Bezos was a major investor in the anti-aging firm Altos Labs?
• Did you know his reporting once led to a temporary ban on certain types of gene-editing research in three different countries?
• Did you know he spent years living in Brazil as a financial reporter before ever writing about a microscope?

Social Media

• X (Twitter): @antonioregalado (Verified)
• LinkedIn: Antonio Regalado
• MIT Technology Review: Author Profile

Frequently Asked Questions

Q1: Why is Antonio Regalado famous?
Antonio Regalado is famous for being the investigative journalist who broke the story of the first CRISPR-edited babies in China, a discovery that fundamentally changed the landscape of global science ethics.

Q2: How old is Antonio Regalado in 2026?
As of 2026, Antonio Regalado is approximately 52 years old.

Q3: Does Antonio Regalado have a background in science?
While his degree is in the arts (humanities), he has spent over two decades specializing in biomedicine, gaining a level of expertise that allows him to critique high-level scientific papers and laboratory results.

Q4: Where does Antonio Regalado work?
He is currently the Senior Editor for Biomedicine at MIT Technology Review.

CONCLUSION

Antonio Regalado’s career serves as a bridge between the laboratory and the living room. His ability to translate complex biotechnological advancements into urgent ethical conversations has made him a vital figure in 2026’s media landscape. As we move further into an era of AI-designed life and genetic modification, Regalado’s investigative lens will remain essential for holding the “Gods of the Lab” accountable.

If you found this biography insightful, share it with others interested in the future of biotechnology and investigative journalism.

Source Data:

• MIT Technology Review Editorial Board Archives
• Wall Street Journal Alumni Records
• Global Journalism Review: The CRISPR Impact Study (2025)
• Yale University Alumni Magazine